Kaundinya Ganesh Venkataraman 4
4 · MOMENTA PHARMACEUTICALS INC · Filed May 10, 2018
Insider Transaction Report
Form 4
Venkataraman Ganesh
Senior V.P., Research
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-05-08−1,409→ 15,504 total→ Common Stock (1,409 underlying) - Exercise/Conversion
Common Stock
2018-05-08+1,409→ 496,709 total - Sale
Common Stock
2018-05-08$18.09/sh−493$8,918→ 496,216 total
Footnotes (4)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.